Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 06 12 2018
revised: 27 02 2019
pubmed: 16 5 2019
medline: 1 5 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

This study examined the differences in cognitive function between middle-aged and older adults with insomnia disorder, insomnia symptoms only (ISO) or no insomnia symptoms (NIS), in the context of other health and lifestyle factors. Twenty-eight thousand four hundred eighty-five participants >45 years completed questionnaires, physical examinations, and neuropsychological testing across domains of processing speed, memory, and executive functions. An eight-question instrument assessed participants' sleep, defining subjects with insomnia symptoms, probable insomnia disorder (PID), or NIS. The associations between these three groups and cognitive performance were examined with linear regression models adjusted for lifestyle and clinical factors. PID was identified in 1,068 participants (3.7% of the sample) while 7,813 (27.5%) experienced ISO. Participants with PID exhibited greater proportions of adverse medical and lifestyle features such as anxiety, depression, and diabetes than both other groups. Analyses adjusting for age, sex, education, as well as medical and lifestyle factors demonstrated that adults with PID exhibited declarative memory deficits (Rey Auditory Verbal Learning Test) compared with ISO or NIS. Adults with insomnia symptoms exhibited better performance on a task of mental flexibility than both other groups. These findings suggest that insomnia disorder in middle-aged and older adults is associated with poorer health outcomes and worse memory performance than adults with insomnia symptoms alone or without any sleep complaints, even after adjustment for comorbidities. The assessment of longitudinal data within this cohort will be critical to understand if insomnia disorder may increase the risk of further cognitive decline.

Identifiants

pubmed: 31089710
pii: 5488740
doi: 10.1093/sleep/zsz114
pmc: PMC6685318
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : LSA 9447
Pays : Canada
Organisme : CIHR
ID : FDN154291
Pays : Canada
Organisme : CIHR
ID : MOP 142191
Pays : Canada
Organisme : CIHR
ID : PJT 153115
Pays : Canada
Organisme : CIHR
ID : PJT 156125
Pays : Canada

Informations de copyright

© Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Références

Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Behav Sleep Med. 2008;6(1):32-54
pubmed: 18412036
J Am Geriatr Soc. 2001 Dec;49(12):1628-32
pubmed: 11843995
Psychol Sci. 2006 Oct;17(10):891-8
pubmed: 17100790
J Clin Sleep Med. 2014 Jun 15;10(6):613-21
pubmed: 24932140
Neurology. 2006 Oct 10;67(7):1208-14
pubmed: 17030754
Science. 2013 Oct 18;342(6156):373-7
pubmed: 24136970
Nat Neurosci. 2015 Jul;18(7):1051-7
pubmed: 26030850
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Respirology. 2013 Jan;18(1):61-70
pubmed: 22913604
Behav Sleep Med. 2007;5(4):279-96
pubmed: 17937583
J Gerontol. 1983 May;38(3):333-9
pubmed: 6841929
Sleep Med Rev. 2009 Aug;13(4):287-93
pubmed: 19246219
J Sleep Res. 2008 Sep;17(3):335-43
pubmed: 18844819
Neuropsychiatr Dis Treat. 2016 Feb 15;12:339-48
pubmed: 26929626
Sleep Med. 2009 Oct;10(9):952-60
pubmed: 19748312
Physiol Rev. 2013 Apr;93(2):681-766
pubmed: 23589831
Sleep. 2016 Jan 01;39(1):217-26
pubmed: 26414903
Neuroepidemiology. 2006;26(2):93-101
pubmed: 16352912
Sleep Med. 2017 Oct;38:85-91
pubmed: 29031762
Sleep. 2015 Apr 01;38(4):623-31
pubmed: 25348123
J Clin Sleep Med. 2018 Feb 15;14(2):237-244
pubmed: 29394962
Curr Opin Psychiatry. 2014 Nov;27(6):478-83
pubmed: 25188896
Can J Aging. 2009 Sep;28(3):221-9
pubmed: 19860977
Chest. 2017 Aug;152(2):435-444
pubmed: 28153671
Neurology. 2017 Aug 1;89(5):445-453
pubmed: 28679595
J Gerontol B Psychol Sci Soc Sci. 2009 Mar;64(2):180-7
pubmed: 19204069
Curr Drug Abuse Rev. 2017;9(2):76-79
pubmed: 27492358
Sleep Med Rev. 2012 Feb;16(1):83-94
pubmed: 21636297
Physiol Behav. 1999 May;66(3):485-92
pubmed: 10357438
Sleep. 2010 Apr;33(4):459-65
pubmed: 20394314
Rev Neurosci. 2010;21(3):187-221
pubmed: 20879692
Sleep. 2005 Dec;28(12):1579-87
pubmed: 16408418
J Am Geriatr Soc. 2014 Jun;62(6):1073-81
pubmed: 24786726
Lancet Neurol. 2014 Oct;13(10):1017-28
pubmed: 25231524
J Epidemiol Community Health. 2011 Sep;65(9):820-4
pubmed: 20675705
Sleep Med Rev. 2001 Dec;5(6):423-445
pubmed: 12531152
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86
pubmed: 26402085
J Am Geriatr Soc. 2001 Sep;49(9):1185-9
pubmed: 11559377
Sleep. 2007 Sep;30(9):1205-11
pubmed: 17910392
J Cogn Neurosci. 1997 Jul;9(4):534-47
pubmed: 23968216
Am J Clin Exp Immunol. 2017 Dec 20;6(6):92-96
pubmed: 29348984
Sleep. 2011 Aug 01;34(8):1103-10
pubmed: 21804672
Sleep Med. 2006 Mar;7(2):123-30
pubmed: 16459140
Sleep Med Rev. 2016 Dec;30:11-24
pubmed: 26687279
Annu Rev Public Health. 2015 Mar 18;36:417-40
pubmed: 25785893
J Affect Disord. 2008 Feb;106(1-2):1-27
pubmed: 17707915
Sleep. 2009 Mar;32(3):295-301
pubmed: 19294949
Psychol Bull. 2013 Jan;139(1):81-132
pubmed: 22642228

Auteurs

Nathan E Cross (NE)

Institut Universitaire de Geriatrie de Montreal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montreal, Canada.
PERFORM Centre, Concordia University, Montreal, Canada.
Center for Studies in Behavioral Neurobiology, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.

Julie Carrier (J)

Institut Universitaire de Geriatrie de Montreal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hopital du Sacre- Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Canada.

Ronald B Postuma (RB)

Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hopital du Sacre- Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Canada.
Department of Neurology, McGill University - Montreal General Hospital, Montreal, Canada.

Nadia Gosselin (N)

Canadian Sleep and Circadian Network, Montreal, Canada.
Center for Advanced Research in Sleep Medicine, Hopital du Sacre- Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Canada.
Department of Psychology, Universite de Montreal, Montreal, Canada.

Lisa Kakinami (L)

PERFORM Centre, Concordia University, Montreal, Canada.
Department of Mathematics and Statistics, Concordia University.

Cynthia Thompson (C)

Center for Advanced Research in Sleep Medicine, Hopital du Sacre- Coeur de Montreal, CIUSSS du Nord-de-l'Ile-de-Montreal, Montreal, Canada.

Florian Chouchou (F)

Institut Universitaire de Geriatrie de Montreal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montreal, Canada.
PERFORM Centre, Concordia University, Montreal, Canada.
IRISSE Laboratory, UFR SHE, University of La Réunion, Le Tampon, France.

Thien Thanh Dang-Vu (TT)

Institut Universitaire de Geriatrie de Montreal and CRIUGM, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montreal, Canada.
PERFORM Centre, Concordia University, Montreal, Canada.
Center for Studies in Behavioral Neurobiology, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, Canada.
Canadian Sleep and Circadian Network, Montreal, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH